 |
|
Global varicella vaccination programs
Young Hwa Lee, Young June Choe, Jia Lee, Eunseong Kim, Jae Young Lee, Kwan Hong, Yoonsun Yoon, Yun-Kyung Kim
Clin Exp Pediatr. 2022;65(12):555-562. Published online 2022 Nov 2 DOI: https://doi.org/10.3345/cep.2021.01564
|
|
Citations to this article as recorded by
 Parental perceptions of chickenpox and the varicella vaccine: A qualitative systematic review
Zoe Jordan, Emma Rowland
Vaccine.2024; 42(2): 75. CrossRef Effectiveness of the combined MMRV Priorix-Tetra™ vaccine against varicella in a large Italian region: A case-control study
Francesca Fortunato, Angelo Musco, Giuseppina Iannelli, Martina Meola, Pier Luigi Lopalco, Domenico Martinelli
Vaccine.2024; 42(7): 1608. CrossRef Study on Varicella-Zoster Virus Antibody Levels among Children Aged 1–7 Years in Changzhou, China
Dan Wu, Changlei Han, Suting Xiong, Peipei Zhang, Han Gao, Junhong Li, Fengming Wang, Qinwen Xu, Xin Dong
Vaccines.2024; 12(3): 290. CrossRef Expanded spectrum of varicella disease and the need for vaccination in India
Padma Srikanth, Ilakkiya Arumugam, Seetha N. Jeganathan, Rithvik Ramesh, Lakshmi Narasimhan Ranganathan, Shanthi Vijayaraghavan
Human Vaccines & Immunotherapeutics.2024;[Epub] CrossRef Nanopore sequencing in distinguishing between wild-type and vaccine strains of Varicella-Zoster virus
Yuto Fukuda, Takako Suzuki, Ken-ichi Iwata, Kazunori Haruta, Makoto Yamaguchi, Yuka Torii, Atsushi Narita, Hideki Muramatsu, Yoshiyuki Takahashi, Jun-ichi Kawada
Vaccine.2024; 42(11): 2927. CrossRef Is there a need for an alternative varicella vaccine?
Alemnew F Dagnew
The Lancet Infectious Diseases.2024;[Epub] CrossRef Immunogenicity and Efficacy of Vaccination in People Living with Human Immunodeficiency Virus
Eeva Tortellini, Yann Collins Fosso Ngangue, Federica Dominelli, Mariasilvia Guardiani, Carmen Falvino, Fabio Mengoni, Anna Carraro, Raffaella Marocco, Patrizia Pasculli, Claudio Maria Mastroianni, Maria Rosa Ciardi, Miriam Lichtner, Maria Antonella Zinga
Viruses.2023; 15(9): 1844. CrossRef Cross-reactive humoral immunity of clade 2 Oka and MAV/06 strain-based varicella vaccines against different clades of varicella–zoster virus
Ji-Young Hwang, Yunhwa Kim, Kyung-Min Lee, Ok Sarah Shin, Jeong-An Gim, Younchul Shin, Hosun Park
Human Vaccines & Immunotherapeutics.2023;[Epub] CrossRef Assessing vaccine effectiveness for varicella in Wuxi, China: a time-series analysis
Lingling Wang, Xu Yang, Xuwen Wang, Ping Shi, Xuhui Zhang
Annals of Medicine.2023;[Epub] CrossRef Immunogenicity and Safety of a Newly Developed Live Attenuated Varicella Vaccine in Healthy Children: A Multi-National, Randomized, Double-Blinded, Active-Controlled, Phase 3 Study
Ui Yoon Choi, Ki Hwan Kim, Hye-Kyung Cho, Dong Ho Kim, Sang Hyuk Ma, Young Youn Choi, Chun Soo Kim, Maria Rosario Capeding, Ilya Angelica Rochin Kobashi, Hun Kim, Ji Hwa Ryu, Su Jeen Lee, Ho Keun Park, Jong-Hyun Kim
Vaccines.2023; 11(9): 1416. CrossRef Safety of Interchanging the Live Attenuated MAV/06 Strain and OKA Strain Varicella Vaccines in Children
Hyun Mi Kang, Gwanglok Kim, Young June Choe
Vaccines.2023; 11(9): 1442. CrossRef A booster administration of the OKA/SK strain causes fatal disseminated varicella in an immunocompetent child
Hyun Mi Kang, Kyu Ri Kang, Ye Ji Kim, Jin Han Kang, Soo‐Young Lee
Journal of Medical Virology.2023;[Epub] CrossRef The Epidemiology of Chickenpox in England, 2016–2022: An Observational Study Using General Practitioner Consultations
Megan Bardsley, Paul Loveridge, Natalia G. Bednarska, Sue Smith, Roger A. Morbey, Gayatri Amirthalingam, William H. Elson, Chris Bates, Simon de Lusignan, Daniel Todkill, Alex J. Elliot
Viruses.2023; 15(11): 2163. CrossRef
|